| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |